Literature DB >> 19662923

Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey.

Timothy Bell1, Kathy Annunziata, John B Leslie.   

Abstract

OBJECTIVE: To characterize the impact of opioid-induced constipation (OIC) on healthcare resource use, work productivity, and health-related quality of life (HRQOL) in patients receiving chronic opioid therapy.
DESIGN: Data were collected via Internet questionnaires during the international National Health and Wellness Survey (NHWS) 2004 from individuals aged > or = 18 years who reported taking opioids for > or = 6 months. Healthcare resource utilization, Work Productivity, and Activity Impairment, and Short-Form 8 (SF-8) questionnaire responses were compared between those who did or did not report OIC.
RESULTS: Data were available from 2,430 individuals receiving opioids, of whom 359 reported OIC. Participants with OIC reported significantly more physician visits (mean difference 3.84 visits; p < 0.05) and alternative care provider visits (mean difference 1.73 visits; p < 0.05) over the previous 6 months than those without OIC; however, no significant differences in emergency room visits or number of days of hospitalization were observed. Respondents with OIC also reported significantly greater time missed from work, impairment while working, overall work impairment, and activity impairment (p < 0.05 for all comparisons). HRQOL scores were significantly lower in the OIC group than those without OIC on both the physical and mental components of the SF-8 questionnaire (p < 0.05 for both comparisons).
CONCLUSIONS: The survey results reflect a negative impact of OIC on individuals' HRQOL and on society in terms of healthcare resource use and work productivity beyond that imposed by patients' pain conditions. These findings indicate a need for effective treatment for opioid-induced constipation in patients receiving chronic opioid therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19662923     DOI: 10.5055/jom.2009.0014

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  34 in total

Review 1.  Opioid use and misuse: health impact, prevalence, correlates and interventions.

Authors:  Maria Bolshakova; Ricky Bluthenthal; Steve Sussman
Journal:  Psychol Health       Date:  2019-06-08

Review 2.  Pathophysiology and management of opioid-induced constipation: European expert consensus statement.

Authors:  Adam D Farmer; Asbjørn M Drewes; Giuseppe Chiarioni; Roberto De Giorgio; Tony O'Brien; Bart Morlion; Jan Tack
Journal:  United European Gastroenterol J       Date:  2018-12-14       Impact factor: 4.623

3.  Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer Pain.

Authors:  Ancilla W Fernandes; David M Kern; Catherine Datto; Yen-Wen Chen; Charles McLeskey; Ozgur Tunceli
Journal:  Am Health Drug Benefits       Date:  2016-05

Review 4.  The 'mystery' of opioid-induced diarrhea.

Authors:  Silviu Bril; Yoav Shoham; Jeremy Marcus
Journal:  Pain Res Manag       Date:  2011 May-Jun       Impact factor: 3.037

5.  Medicate or Meditate? Greater Pain Acceptance is Related to Lower Pain Medication Use in Persons With Chronic Pain and Spinal Cord Injury.

Authors:  Anna L Kratz; John F Murphy; Claire Z Kalpakjian; Philip Chen
Journal:  Clin J Pain       Date:  2018-04       Impact factor: 3.442

Review 6.  Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.

Authors:  Richard L Rauck
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

7.  Assessment of a Stool Symptom Screener and Understanding the Opioid-Induced Constipation Symptom Experience.

Authors:  Karin S Coyne; Brooke M Currie; William C Holmes; Joseph A Crawley
Journal:  Patient       Date:  2015-08       Impact factor: 3.883

8.  Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.

Authors:  Masanori Mori; Yongli Ji; Santosh Kumar; Takamaru Ashikaga; Steven Ades
Journal:  Int J Clin Oncol       Date:  2016-09-15       Impact factor: 3.402

9.  Self-reports of medication side effects and pain-related activity interference in patients with chronic pain: a longitudinal cohort study.

Authors:  Marc O Martel; Patrick H Finan; Andrew J Dolman; Subu Subramanian; Robert R Edwards; Ajay D Wasan; Robert N Jamison
Journal:  Pain       Date:  2015-06       Impact factor: 7.926

Review 10.  Clinical utility of naloxegol in the treatment of opioid-induced constipation.

Authors:  Heather C Bruner; Rabia S Atayee; Kyle P Edmonds; Gary T Buckholz
Journal:  J Pain Res       Date:  2015-06-12       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.